FAILED FERTILITY THERAPY AND SUBSEQUENT MAJOR ADVERSE CARDIOVASCULAR EVENTS  by Udell, Jacob A. et al.
Young Investigator Awards Competition
A2163
JACC April 1, 2014
Volume 63, Issue 12
FAiled Fertility therApy And subseQuent MAjor Adverse cArdiovAsculAr events
Oral Contributions
Room 147 B
Monday, March 31, 2014, 11:45 a.m.-Noon
Session Title: Young Investigator Awards Competition: Cardiovascular Health Outcomes and Population Genetics
Abstract Category: Cardiovascular Health Outcomes and Population Genetics
Presentation Number: 931-09
Authors: Jacob A. Udell, Hong Lu, Donald A. Redelmeier, Women’s College Hospital, Toronto, Canada, Institute for Clinical Evaluative Sciences, 
University of Toronto, Toronto, Canada
background: Fertility drug therapy is often prescribed on a repeated basis at high doses with unknown long-term cardiovascular health effects. 
We investigated to what extent failed fertility therapy as compared with successful fertility therapy might contribute to subsequent Major Adverse 
Cardiovascular Events [MACE].
Methods: We performed a population-based cohort analysis of adult women who received fertility therapy in Ontario, Canada between April 
1993 and March 2011, distinguishing those who did and did not give birth within a year following their last fertility treatment. Multivariable risk 
models examined the association (odds ratio [OR]) between failed fertility therapy and risk of a MACE defined as a composite of non-fatal coronary 
ischemia, stroke, transient ischemic attack, heart failure, or thromboembolism. Further analyses accounted for number of fertility cycles and the 
distinction of secondary infertility.
results: Among 28,442 women who received fertility therapy during the study period, 19,093 (67%) failed to gave birth whereas 9,349 (33%) 
succeeded in giving birth. After 6.1 years of median follow-up, women with failed fertility therapy more frequently developed a MACE compared with 
successful therapy (6.4% vs. 5.3%; OR 1.23, 95% CI, 1.01-1.50, p=0.04). The increased risk of MACE persisted in women with low vs high dose 
fertility therapy (OR 1.32 vs 1.13, respectively) and extended to both primary and secondary infertility (OR 1.20 vs 1.35, respectively).
conclusion: Failed fertility therapy is associated with an increased risk of major adverse cardiovascular events and merits attentions for 
subsequent cardiac care.
